Nurse Practitioner, Family · Dothan, AL
NPI
1174829915
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1450 Ross Clark Cir Ste 400
Dothan, AL, 36301
Phone (334) 305-0400
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
1,611 services
Medicare patients, 2024
646
Average age 75
Drug cost, 2024
$2.1M
5,414 prescriptions
Company payments, 2025
$2,685
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keesha Tyler was code 99214 (office e&m - established), 797 times for 525 patients. In total Keesha Tyler billed 1,611 services in 23 codes, and Medicare paid $82K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 797 | 525 | $71.15 | $57K |
| 71046 X-ray - Chest | Office | 405 | 298 | $18.49 | $7,488 |
| 99213 Office E&M - Established | Office | 95 | 93 | $48.69 | $4,625 |
| 99215 Office E&M - Established | Office | 73 | 60 | $103.05 | $7,523 |
| 94010 Pulmonary Function Testing | Office | 68 | 64 | $14.56 | $990 |
| 94618 Pulmonary Function Testing | Office | 50 | 48 | $17.94 | $897 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 24 | 23 | $10.64 | $255 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 23 | 12 | $31.00 | $713 |
| 36415 Venipuncture Blood Collection | Office | 20 | 16 | $8.65 | $173 |
| 99203 Office E&M - New | Office | 18 | 18 | $57.45 | $1,034 |
By year: 2022 $92K for 1,814 services; 2023 $91K for 1,812 services; 2024 $82K for 1,611 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 20 | 16 | $8.65 | $173 |
Medicare prescription drug claims, 2024
In 2024, the drug Keesha Tyler prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 967 prescriptions and refills. In total Keesha Tyler wrote 5,414 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 967 | 1,122 | 191 | $719K |
| Prednisone Generic | 889 | 973 | 376 | $2,534 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 502 | 595 | 190 | $12K |
| Doxycycline Hyclate Generic | 383 | 392 | 218 | $4,271 |
| Azithromycin Generic | 283 | 404 | 121 | $3,516 |
| Cefdinir Generic | 207 | 207 | 134 | $3,804 |
| Breo Ellipta Fluticasone/Vilanterol | 204 | 238 | 43 | $94K |
| Montelukast Sodium Generic | 165 | 363 | 57 | $1,546 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 112 | 130 | 35 | $82K |
| Ventolin Hfa Albuterol Sulfate | 101 | 137 | 46 | $9,458 |
| Symbicort Budesonide/Formoterol Fumarate | 95 | 121 | 28 | $28K |
| Spiriva Respimat Tiotropium Bromide | 95 | 124 | 24 | $65K |
| Azelastine Hcl Generic | 82 | 106 | 33 | $1,848 |
| Levofloxacin Generic | 72 | 72 | 41 | $262 |
| Fluticasone Propionate Generic | 67 | 117 | 33 | $1,246 |
Brand drugs: - claims; generic drugs: 3,051 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Keesha Tyler $2,685 ($2,685 in general payments such as food, travel and fees) from 20 companies. The largest payer was GlaxoSmithKline, LLC. with $414.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 26 | $414 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $334 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $299 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 14 | $298 |
| Amgen Inc. AMGN | 14 | $250 |
| Genzyme Corporation SNY | 7 | $179 |
| Verona Pharma, Inc. VRNA | 9 | $169 |
| Regeneron Healthcare Solutions, Inc. REGN | 8 | $161 |
| Insmed, Inc. INSM | 6 | $140 |
| United Therapeutics Corporation UTHR | 5 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.